Oct 30 (Reuters) - Diagnostics firm Bio-Rad Laboratories (BIO.N), opens new tab posted third-quarter profit above Wall Street estimates on Wednesday, helped by a recovery in demand for analytical ...

Luminex’s xMAP technology is a microsphere-based multiplexing system. Multiplex assays provide attractive time and labor advantages over singleplex ELISA-based assays. In the Luminex assays, a ...

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through ...

Bio-Rad Laboratories, Inc.’s BIO robust QX600 Droplet Digital PCR (ddPCR) platform positions the company well to capture a major share in the booming digital PCR space. The clinical diagnostics ...

The recurrent β chain signaling cytokines — granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-3 and IL-5 — can control the growth, activities and differentiation of eosinophils ...

A group led by Prof. Horacio Cabral has discovered a new method to construct protein complex-based therapeutics. Prof. Cabral is a visiting scientist from the Innovation Center for NanoMedicine ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

If you're writing a corporate bio, highlight your achievements within the company. Avoid generic statements and be truthful when describing your skills and experiences. Focus on your unique ...

Oct. 31, 2024 — As critical responders, macrophages can perceive helpful biotechnology as threats. If not created with the right materials or mechanical forces, these devices can trigger an ...

*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...